Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1922]
News [4599]
Articles [467]
Editorials [10]
Conferences [114]
elearning [42]

miRNA screening through nipple aspiration sampling

Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands
miRNA screening through nipple aspiration sampling ( Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands )
26 Jul 2016

Breast cancer in the 21st century

Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA
Breast cancer in the 21st century ( Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA )
25 Jul 2016

Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists

Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA
Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists ( Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA )
25 Jul 2016

The steady progress of targeted therapies

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
The steady progress of targeted therapies ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
20 Jul 2016

DNA repair and mutations as targets for personalised therapy

Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA
DNA repair and mutations as targets for personalised therapy ( Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA )
15 Jul 2016

Obesity promotes pancreatic cancer progression and resistance

Dr Joao Incio - Massachusetts General Hospital, Boston, USA
Obesity promotes pancreatic cancer progression and resistance ( Dr Joao Incio - Massachusetts General Hospital, Boston, USA )
14 Jul 2016

ERß expression predicts breast cancer risk in hyperplasia

Dr Tina Hieken - Mayo Clinic, Rochester, USA
ERß expression predicts breast cancer risk in hyperplasia ( Dr Tina Hieken - Mayo Clinic, Rochester, USA )
14 Jul 2016

Polygenic risk and the targeted prevention of cancer

Prof Paul Pharoah - University of Cambridge, Cambridge, UK
Polygenic risk and the targeted prevention of cancer ( Prof Paul Pharoah - University of Cambridge, Cambridge, UK )
13 Jul 2016

'Rewiring' tumour susceptibility

Dr Michael Yaffe - MIT, Cambridge, USA
'Rewiring' tumour susceptibility ( Dr Michael Yaffe - MIT, Cambridge, USA )
13 Jul 2016

Personalising breast cancer therapy

Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA
Personalising breast cancer therapy ( Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA )
4 Jul 2016

Results of the MINDACT clinical trial

Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France
Results of the MINDACT clinical trial ( Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France )
1 Jul 2016

Breast and cervical cancer rates influenced by HRT, not contraceptive pill

Prof Valerie Beral - University of Oxford, Oxford, UK
Breast and cervical cancer rates influenced by HRT, not contraceptive pill ( Prof Valerie Beral - University of Oxford, Oxford, UK )
30 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation